{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T03:38:34Z","timestamp":1760585914793,"version":"3.41.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore the clinical efficacy and adverse reactions of Jiawei Maxing Shigan Tang (JMST; a modified decoction of ephedra, apricot kernel, gypsum, and licorice) combined with western medicine in the symptomatic treatment of COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we retrospectively collected the basic data of 48 patients with COVID-19 who were discharged from our hospital between January 20 and February 28, 2020. Besides, the blood routines, biochemical indexes, nucleic acid detection results, clinical symptoms, lung imaging improvements, adverse reactions, and other clinical data of these patients before and after treatment were recorded. Finally, we drew comparisons between the outcomes and adverse reactions of patients in the combined treatment group (therapeutic regimen recommended by authoritative guidelines and supplemented by JMST) and the conventional treatment group (therapeutic regimen recommended by authoritative guidelines).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were no significant differences in age, gender, clinical classification, and underlying medical conditions between the combined treatment group (28 cases) and the conventional treatment group (20 cases). However, the combined treatment group presented superior results to the conventional treatment group in several key areas. For instance, patients produced negative nasal\/throat swab-based nucleic acid detection results in a shorter time, clinical symptoms were more effectively alleviated, and the absorption time of lung exudation was shorter (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). Furthermore, the combined treatment group had a shorter length of stay (LOS) and faster lymphocyte recovery duration than the conventional treatment group, although the differences were not statistically significant. Moreover, there were no significant differences concerning gastrointestinal reaction, hepatic injury, renal impairment, myocardial injury, and other adverse reactions between the two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results of this study indicate that JMST combined with the recommended therapeutic regimen enhances the recovery of COVID-19 patients without increasing the risk of adverse reactions. Therefore, this therapy promotes positive outcomes for COVID-19 patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1028171","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T14:52:22Z","timestamp":1666277542000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Application of Jiawei Maxing Shigan Tang in the treatment of COVID-19: An observational study"],"prefix":"10.3389","volume":"9","author":[{"given":"Jia","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zai-Lin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1152\/physiolgenomics.00089.2020","article-title":"The COVID-19 pandemic: a global health crisis","volume":"52","author":"Pollard","year":"2020","journal-title":"Physiol Genomics."},{"key":"B2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","article-title":"A review of coronavirus disease-2019 (COVID-19)","volume":"87","author":"Singhal","year":"2020","journal-title":"Indian J Pediatr"},{"key":"B3","unstructured":"66). [EB\/OL]. National Administration of Traditional Chinese Medicine, National Health Commission of the People's Republic of China"},{"key":"B4","unstructured":"77). [EB\/OL]. National Administration of Traditional Chinese Medicine, National Health Commission of the People's Republic of China"},{"key":"B5","unstructured":"103). [EB\/OL]. National Administration of Traditional Chinese Medicine, National Health Commission of the People's Republic of China"},{"key":"B6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jmii.2020.05.001","article-title":"systematic review of asymptomatic infections with COVID-19","volume":"54","author":"Gao","year":"2021","journal-title":"J Microbiol Immunol Infect."},{"key":"B7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chmed.2020.03.004","article-title":"Pay attention to situation of SARS-CoV-2 and TCM advantages in treatment of novel coronavirus infection","volume":"12","author":"Liu","year":"2020","journal-title":"Chin Herb Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10096-020-04088-z","article-title":"Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review","volume":"40","author":"Dao","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.16466\/j.issn1005-5509.2020.03.003","article-title":"Interpretation of Recommended Scheme for Prevention and Treatment of COVID-19 by Traditional Chinese Medicine (Trial Version 4) in Zhejiang Province","volume":"3","author":"Yang","year":"2020","journal-title":"J Zhejiang Chin Med Univ."},{"key":"B10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.13288\/j.11-2166\/r.2020.04.002","article-title":"Clinical features and syndrome differentiation of novel coronavirus pneumonia in traditional chinese medicine","volume":"61","author":"Wang","year":"2020","journal-title":"J Tradit Chin Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1186\/s13063-020-04970-3","article-title":"Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial","volume":"21","author":"Zeng","year":"2020","journal-title":"Trials."},{"key":"B12","first-page":"358","article-title":"The correlation investigation research of distribution characteristics of health status and TCM physical type in Hangzhou Zhejiang","volume":"5","author":"Zhang","year":"2011","journal-title":"J Tradit Chin Med."},{"key":"B13","first-page":"1","article-title":"Discussion on Traditional Chinese Medicine Prevention and Treatment Strategies of New Coronavirus Pneumonia (COVID-19) from the Perspective of Cold and Wet Epidemic [J\/OL]","author":"Tong","year":"2020","journal-title":"J Tradit Chin Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"868","DOI":"10.13288\/j.11-2166\/r.2004.11.042","article-title":"Reassessment of the Writings from Huang Di Nei Jing Su Wen","volume":"11","author":"Gu","year":"2004","journal-title":"J Tradit Chin Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.13424\/j.cnki.mtcm.2021.04.020","article-title":"Clinical Study on the Treatment of Chronic Obstructive Pulmonary Disease Combined with Pulmonary Infection with JMST","volume":"41","author":"Zhu","year":"2021","journal-title":"Modern Traditional Chinese Medicine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.16040\/j.cnki.cn15-1101.2021.09.032","article-title":"Clinical Efficacy of JMST in the Treatment of Wind-warm Disease with Syndrome of Pathogenic Heat Congesting Lung in Community-acquired Pneumonia","volume":"40","author":"Zhong","year":"2021","journal-title":"Inner Mongolia J Tradit Chin Med."},{"key":"B17","first-page":"82","article-title":"Treating 157 Cases of Infantile Pneumonia of Phlegm-heat Stagnating Lung Patternwith Modified Maxing Shigan Decoction","volume":"32","author":"Wang","year":"2019","journal-title":"Western J Tradit Chin Med."},{"key":"B18","first-page":"69","article-title":"A pharmacological study of pneumonia mixture II (JMST)","volume":"1","author":"Liu","year":"1979","journal-title":"J Peking Univ."},{"key":"B19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.13633\/j.cnki.zjtcm.2019.05.013","article-title":"Clinical Observation on 35 Cases of Ventilator-associated Pneumonia Prevented by Modified Shenling Baizhu Powder","volume":"54","author":"Ye","year":"2019","journal-title":"Zhejiang J Tradit Chin Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.13633\/j.cnki.zjtcm.2018.05.014","article-title":"Observation on 30 Cases of Ventilator-associated Pneumonia in Ventilator-dependent Patients Prevented by Shenling Baizhu Powder","volume":"53","author":"Shi","year":"2018","journal-title":"Zhejiang J Tradit Chin Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/jcm9020575","article-title":"Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China","volume":"9","author":"Deng","year":"2020","journal-title":"J Clin Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1028171\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T14:52:39Z","timestamp":1666277559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1028171\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":22,"alternative-id":["10.3389\/fmed.2022.1028171"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1028171","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"article-number":"1028171"}}